News
- Palifermin in head/neck ca
- Published on Aug 08, 2011
Palifermin (recombinant human keratinocyte growth factor) may have a role in the treatment of mucositis in patients undergoing chemoradiotherapy for head and neck cancer, two trials suggest (J Clin Oncol 2011; doi: 10.1200/ JCO.2010.32.4095 & 4103).
- Hope for chronic kidney disease?
- Published on Aug 08, 2011
A novel treatment for chronic kidney disease (CKD) may offer the prospect of arresting progression or even improving kidney function in patients with diabetes if long-term studies bear out the promise of an early trial.
- $4.3 billion pledged for future vaccines
- Published on Aug 08, 2011
The Global Alliance for Vaccines and Immunisation (www.gavialliance.org) has been pledged $4.3 billion to immunise a quarter of a billion children in developing countries by 2015, it was announced at a London conference on 13 June. Pharmaceutical companies promised to cut the prices of vaccines supported by GAVI.
- First-in-class approved for COPD
- Published on Jul 30, 2010
Nycomed’s novel anti-inflammatory roflumilast will soon be available in the EU following a positive opinion from the European Medicine Agency’s Committee for Medicinal Products for Human Use.
- New cancer drug targets microtubules
- Published on Jul 30, 2010
Data presented at the American Association of Cancer Research Annual Meeting in Washington DC show that Basilea’s novel small molecule anticancer drug BAL 101553 is potentially effective against a wide range of tumour types, including some resistant to chemotherapy.
